Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-07-12FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for NEUPRO (rotigotine) filed by UCB, Inc., indicating a regulatory expansion to the product’s label…
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: Low Frequency Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease [NA]
A completed clinical trial evaluating low frequency deep brain stimulation of the subthalamic nucleus in Parkinson's disease with cognitive …
-
FDA label_change · 2021-06-16FDA Approved: ZELAPAR — Supplemental Application (Bausch Health US, LLC)
FDA approves Zelapar (selegiline hydrochloride) supplemental application to update the product labeling. The change relates to the labeling …
-
FDA approval · 2021-06-11FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE — Original Application (Vitruvias Therapeutics, Inc.)
FDA approved an extended-release pramipexole dihydrochloride tablet under an Original Application for Vitruvias Therapeutics, indicated for …
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD) [Phase 3]
Phase 3 trial comparing Levodopa-Carbidopa intestinal gel to optimized medical treatment for non-motor symptoms in advanced Parkinson's dise…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Intraoperative Investigation of a Directional Lead and Local Field Potentials for the Optimization of Stimulation Efficacy
Clinical trial investigating intraoperative directional lead and local field potentials to optimize stimulation efficacy for Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2021-05-26Clinical Trial Update: AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia [Phase 2]
Phase 2 clinical trial evaluating AV-101 (L-4-chlorokynurenine) in Parkinson's disease patients with levodopa-induced dyskinesia; status cur…
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.
A completed clinical trial evaluated skin biopsy α-synuclein as a marker for early diagnosis of Parkinson's disease with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Videofluoroscopic Swallowing Study (VFSS) [NA]
A Videofluoroscopic Swallowing Study (VFSS) trial sponsored by Nestlé has been terminated; results were posted in 2021 and the study covered…
-
CLINICAL_TRIALS trial_result · 2021-05-19Clinical Trial Update: Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease? [Phase 1]
Phase 1 trial investigating whether N-Acetylcysteine reduces spontaneous oxidation of central nervous system dopamine in Parkinson's disease…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: Randomised Crossover Trial of DBS of Differential PSA Regions in Parkinson's Disease and Tremor [Phase 2]
A Phase 2 randomized crossover trial investigating deep brain stimulation of differential PSA regions for Parkinson's disease and tremor has…
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: rTMS for the Treatment of Freezing of Gait in Parkinson's Disease [NA]
A completed clinical trial investigating repetitive transcranial magnetic stimulation (rTMS) for freezing of gait in Parkinson's disease; re…
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications [Phase 3]
Extension study assessing safety, tolerability, and efficacy of ABT-SLV187 in advanced Parkinson's disease with persistent motor complicatio…
-
FDA approval · 2021-05-07FDA Approved: CARBIDOPA AND LEVODOPA — Original Application (ScieGen Pharmaceuticals Inc)
FDA approved the original approval application for a generic carbidopa/levodopa product from ScieGen Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON [Phase 4]
Phase 4 trial updating the efficacy of Levodopa/Benserazide Dispersible Tablet on response fluctuations in Parkinson disease patients with d…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease [Phase 4]
Phase 4 trial update on selegiline for excessive daytime sleepiness in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects [Phase 1, Phase 2]
Exploratory Phase 1/2 trial of XP21279 with Lodosyn and Sinemet in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Effects of tDCS Combined With Therapeutic Exercises in Patients With Parkinson's Disease. [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial investigating the effects of transcranial direct current stimulation (tDCS) combined with therapeutic exer…
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Advancing Pre-operative Targeting for Deep Brain Stimulation in the Globus Pallidus Internus [NA]
A terminated clinical trial update related to pre-operative targeting for deep brain stimulation in the globus pallidus internus for Parkins…
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease [Phase 2]
Phase 2 clinical trial investigating SR-Exenatide (PT320) for efficacy and safety in early Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Convection Enhanced Delivery of CSF in DBS for Parkinson's [NA]
Clinical trial completion with results posted for convection-enhanced CSF delivery in DBS for Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Telehealth Cognitive Behavioral Therapy for Depression in Parkinson's Disease (PD) [NA]
A completed clinical trial evaluating telehealth-based cognitive behavioral therapy for depression in Parkinson's disease with results poste…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Deep Brain Stimulation Effects on Gait and Balance in Patients With Parkinson's Disease [NA]
A terminated clinical trial evaluating deep brain stimulation effects on gait and balance in Parkinson's disease with results posted in 2021…
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Long-Term Follow-up Safety After DDS Implantation With/Without CDNF Infusions [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing long-term safety of DDS implantation with or without CDNF infusions in Parkinson disease and related move…
-
FDA approval · 2021-03-12FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application from Aurobindo Pharma Limited for pramipexole dihydrochloride (ANDA 202633).